Morbidity in patients with permanent hypoparathyroidism after total thyroidectomy

Area of Science:

• Endocrinology
• Surgical Oncology
• Nephrology

Background:

• Permanent hypoparathyroidism is a frequent complication after total thyroidectomy.
• Assessing long-term morbidity in patients with and without permanent hypoparathyroidism post-thyroidectomy is crucial.

Purpose of the Study:

• To evaluate the long-term morbidity risks in patients who underwent total thyroidectomy.
• To compare morbidity outcomes between patients with and without permanent hypoparathyroidism after thyroidectomy.

Main Methods:

• Utilized data from the Scandinavian Quality Register for Thyroid, Parathyroid, and Adrenal Surgery.
• Cross-linked registry data with national health registries for comprehensive patient follow-up.
• Defined permanent hypoparathyroidism as >6 months of active vitamin D treatment post-thyroidectomy; analyzed morbidity using multivariable Cox regression.

Main Results:

• A total of 4,828 patients were analyzed with a mean follow-up of 4.5 years.
• 5.0% of patients developed permanent hypoparathyroidism, showing increased risks for renal insufficiency (HR 4.88) and malignancy (HR 2.15).
• Patients with pre-existing cardiovascular disease and permanent hypoparathyroidism had a higher risk of cardiovascular events (HR 1.88).

Conclusions:

• Permanent hypoparathyroidism post-total thyroidectomy is associated with significantly increased long-term morbidity.
• These findings underscore the importance of vigilant monitoring for complications in patients with post-thyroidectomy hypoparathyroidism.